RespireRx Pharmaceuticals Inc (fka RSPI)

[nerdseeksblonde]

this comes up on google,
not sure if anything has changed lately
( I don't usually keep up with licensing)
http://www.cortexpharm.com/html/news/04/01-07-04.html

The more important thing is the series of 10 or so papers
from Lilly ( IIRC, you can check pubmed ) showing a
progressively expanding role for AMPA in depression.
There was a startling problem with SSRI MOA and
time to clinical effect that everyone had to
gloss over. These kind of "subtle" problems are
opportunities for emerging technologies.